Related Experiment Video
Updated: Apr 5, 2026
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Systems Medicine for Multiple Myeloma: A Review on Decision Support Systems
Matthias Ganzinger1, Christian Haux1, Christian Karmen1
1Heidelberg University, Institute of Medical Biometry and Informatics, Heidelberg, Germany.
Abstract:
Systems medicine is a current approach trying to improve treatment for patients with complex diseases by analyzing as much phenotype and genotype data as possible for the disease in question. For individualized treatment decisions in clinical practice, this task has to be supported by an application system with decision support component. For a research project on systems medicine we reviewed methods for decision support. Criteria for selecting a method are derived from characteristics of the data and the diseases. They include, among others: dimensionality of data and existence of a priori models for diseases. As a result we decided to implement a prototype system with a case-based reasoning component for systems medicine on multiple myeloma.
More Related Videos
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Therapeutic Drug Monitoring: Affecting Factors